ProCE Banner Activity

Focus on Integrating CAR T-Cell Therapy Into the Management of Mature B-Cell Lymphoma

Slideset Download
Download this slideset from Zahra Mahmoudjafari, PharmD, BCOP, DPLA, with recent insights for pharmacists on the integration of CAR T-cell therapy into the care of patients with B-cell lymphomas and other B-cell malignancies.

Released: March 12, 2020

Expiration: March 11, 2021

No longer available for credit.

Share

Faculty

Zahra Mahmoudjafari

Zahra Mahmoudjafari, PharmD, BCOP, DPLA

Clinical Pharmacy Manager, Blood and Marrow Transplant Program
Division of Hematological Malignancies and Cellular Therapeutics
PGY2 Oncology Residency Program Director
The University of Kansas Cancer Center
Westwood, Kansas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.

Faculty Disclosure

Primary Author

Zahra Mahmoudjafari, PharmD, BCOP, DPLA

Clinical Pharmacy Manager, Blood and Marrow Transplant Program
Division of Hematological Malignancies and Cellular Therapeutics
PGY2 Oncology Residency Program Director
The University of Kansas Cancer Center
Westwood, Kansas

In this slideset from CCO, review new insights for pharmacists on the use of CAR T-cell therapy for patients with B-cell malignancies